These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

381 related articles for article (PubMed ID: 16333240)

  • 1. Low molecular weight heparins in cardiovascular medicine.
    De Lorenzo F; Dotsenko O; Kakkar VV
    Minerva Cardioangiol; 2005 Dec; 53(6):585-603. PubMed ID: 16333240
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low-molecular-weight heparins in clinical practice.
    Hunt D
    South Med J; 1998 Jan; 91(1):2-10. PubMed ID: 9438394
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of low-molecular-weight heparins in non-ST-segment elevation acute coronary syndromes.
    Nguyen-Ho P; Levine GN
    Panminerva Med; 2002 Jun; 44(2):115-22. PubMed ID: 12032429
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low molecular weight heparins--state-of-the-art and unsolved issues.
    Breddin HK
    Blood Coagul Fibrinolysis; 1993 Dec; 4 Suppl 1():S17-9. PubMed ID: 8180324
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent clinical trials in the treatment of venous thromboembolism and unstable angina with low molecular weight heparins.
    Hirsh J
    Curr Opin Hematol; 1998 Sep; 5(5):360-5. PubMed ID: 9776217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The present and future of heparin, low molecular weight heparins, pentasaccharide, and hirudin for venous thromboembolism and acute coronary syndromes.
    Haas S
    Semin Vasc Med; 2003 May; 3(2):139-46. PubMed ID: 15199477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low-molecular-weight heparin in the treatment of pulmonary embolism.
    Ageno W; Turpie AG
    Semin Vasc Surg; 2000 Sep; 13(3):189-93. PubMed ID: 11005462
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low molecular weight heparins in the treatment of unstable angina.
    Ageno W; Turpie AG
    Minerva Cardioangiol; 2002 Dec; 50(6):643-51. PubMed ID: 12473984
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low molecular weight heparins for arterial thrombosis.
    Nenci GG; Minciotti A
    Vasc Med; 2000; 5(4):251-8. PubMed ID: 11213238
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low-molecular-weight heparins in coronary arterial thrombus disease: a review of the literature.
    Rodman DP
    Pharmacotherapy; 1998; 18(2):265-72. PubMed ID: 9545145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapy of unstable angina with the low molecular weight heparins.
    Ageno W; Turpie AG
    Vasc Med; 2000; 5(4):217-23. PubMed ID: 11213233
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The emerging role of low-molecular-weight heparin in cardiovascular medicine.
    Hirsh J; Bates SM
    Prog Cardiovasc Dis; 2000; 42(4):235-46. PubMed ID: 10661777
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low-molecular-weight heparins for the treatment of acute coronary syndrome and venous thromboembolism in patients with chronic renal insufficiency.
    Lim W; Al Saleh K; Douketis JD
    Thromb Res; 2006; 118(3):409-16. PubMed ID: 16026817
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differences among low-molecular-weight heparins: evidence in patients with acute coronary syndromes.
    Nicolau JC; Cohen M; Montalescot G
    J Cardiovasc Pharmacol; 2009 Jun; 53(6):440-5. PubMed ID: 19365279
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Are all low molecular weight heparins equivalent in the management of venous thromboembolism?
    Fareed J; Jeske W; Fareed D; Clark M; Wahi R; Adiguzel C; Hoppensteadt D
    Clin Appl Thromb Hemost; 2008 Oct; 14(4):385-92. PubMed ID: 18815137
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment of venous thrombosis with low molecular weight heparin. Progress and outlook].
    Fiessinger JN
    Bull Acad Natl Med; 1997 May; 181(5):875-83; discussion 883-5. PubMed ID: 9312362
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of low-molecular-weight heparins in the management of unstable angina and non-ST elevation myocardial infarction.
    Alwi I
    Acta Med Indones; 2008 Oct; 40(4):228-32. PubMed ID: 19530369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Role of low-molecular-weight heparin in acute coronary syndromes].
    Gharbi M; Barakett N; Lahidheb DH; Smiri Z; Fehri W; Azzouzi F; Rahal N; Mhenni H; Haouala H; Guediche M
    Tunis Med; 2002 Dec; 80(12):725-32. PubMed ID: 12664498
    [TBL] [Abstract][Full Text] [Related]  

  • 19. API expert consensus document on management of ischemic heart disease.
    Association of Physicians of India
    J Assoc Physicians India; 2006 Jun; 54():469-80. PubMed ID: 16909697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Low molecular weight heparin--1998 status].
    Marbet GA
    Praxis (Bern 1994); 1999 Apr; 88(18):802-7. PubMed ID: 10409877
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.